Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Reset all filters
01 6Sanofi
02 4GSK
03 2Pfizer Inc
Reset all filters
01 1POWDER FOR SOLUTION
02 1Powder And Solvent For Injection Solution
03 6SOLUTION
04 2SUSPENSION
05 2VAC
Reset all filters
01 2Originator
02 9SCHEDULE D
03 1Withdrawn
Reset all filters
01 1Acwy Vax - Powder And Solvent For
02 1MENJUGATE LIQUID
03 4MENQUADFI
04 2MENVEO
05 2Menactra
06 1NEISVAC-C
07 1NIMENRIX
Reset all filters
01 9Canada
02 1Malta
03 2South Africa
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : SCHEDULE D
Registration Country : Canada
MENINGOCOCCAL GROUP Y POLYSACCHARIDE-TETANUS TOXOID CONJUGATE
Brand Name : MENQUADFI
Dosage Form : SOLUTION
Dosage Strength : 10MCG/0.5ML
Packaging :
Approval Date :
Application Number : 2507161
Regulatory Info : SCHEDULE D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : SCHEDULE D
Registration Country : Canada
MENINGOCOCCAL GROUP A POLYSACCHARIDE-TETANUS TOXOID CONJUGATE
Brand Name : MENQUADFI
Dosage Form : SOLUTION
Dosage Strength : 10MCG/0.5ML
Packaging :
Approval Date :
Application Number : 2507161
Regulatory Info : SCHEDULE D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : SCHEDULE D
Registration Country : Canada
MENINGOCOCCAL GROUP W POLYSACCHARIDE-TETANUS TOXOID CONJUGATE
Brand Name : MENQUADFI
Dosage Form : SOLUTION
Dosage Strength : 10MCG/0.5ML
Packaging :
Approval Date :
Application Number : 2507161
Regulatory Info : SCHEDULE D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : SCHEDULE D
Registration Country : Canada
MENINGOCOCCAL GROUP C POLYSACCHARIDE-TETANUS TOXOID CONJUGATE
Brand Name : MENQUADFI
Dosage Form : SOLUTION
Dosage Strength : 10MCG/0.5ML
Packaging :
Approval Date :
Application Number : 2507161
Regulatory Info : SCHEDULE D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Originator
Registration Country : South Africa
Group A Meningococcal Polysaccharide
Brand Name : Menactra
Dosage Form : VAC
Dosage Strength : 4ug/0.5ml
Packaging : 0.5X1ug/0.5ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Originator
Registration Country : South Africa
Group C Meningococcal Polysaccharide
Brand Name : Menactra
Dosage Form : VAC
Dosage Strength : 4ug/0.5ml
Packaging : 0.5X1ug/0.5ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Withdrawn
Registration Country : Malta
Neisseria Meningitidis Polysaccharide Group C; Neisseria Meningitidis Polysaccharide Group C; Meningococcal Polysaccharide Group W-135
Brand Name : Acwy Vax - Powder And Solvent For
Dosage Form : Powder And Solvent For Injection Solution
Dosage Strength : 50MCG; 50MCG
Packaging :
Approval Date : 2008-09-30
Application Number :
Regulatory Info : Withdrawn
Registration Country : Malta

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : SCHEDULE D
Registration Country : Canada
MENINGOCOCCAL GROUP A OLIGOSACCHARIDE
Brand Name : MENVEO
Dosage Form : SOLUTION
Dosage Strength : 10MCG/0.5ML
Packaging : 0.5ML
Approval Date :
Application Number : 2347393
Regulatory Info : SCHEDULE D
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : SCHEDULE D
Registration Country : Canada
MENINGOCOCCAL GROUP C OLIGOSACCHARIDE
Brand Name : MENVEO
Dosage Form : SOLUTION
Dosage Strength : 5MCG/0.5ML
Packaging : 0.5ML
Approval Date :
Application Number : 2347393
Regulatory Info : SCHEDULE D
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : SCHEDULE D
Registration Country : Canada
MENINGOCOCCAL GROUP C OLIGOSACCHARIDE
Brand Name : MENJUGATE LIQUID
Dosage Form : SUSPENSION
Dosage Strength : 10MCG/0.5ML
Packaging : 0.5ML
Approval Date :
Application Number : 2440709
Regulatory Info : SCHEDULE D
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : SCHEDULE D
Registration Country : Canada
MENINGOCOCCAL POLYSACCHARIDE VACCINE GRP C
Brand Name : NEISVAC-C
Dosage Form : SUSPENSION
Dosage Strength : 10MCG/0.5ML
Packaging : 0.5ML/10X0.5ML/20X0.5ML
Approval Date :
Application Number : 2245057
Regulatory Info : SCHEDULE D
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : SCHEDULE D
Registration Country : Canada
MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C
Brand Name : NIMENRIX
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 5MCG/0.5ML
Packaging : 0.5ML/10X0.5ML
Approval Date :
Application Number : 2402904
Regulatory Info : SCHEDULE D
Registration Country : Canada
